drugset / Trial / NCT00649844
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the efficacy and safety of ziprasidone and clozapine in schizophrenic patients who are resistant and/or intolerant to antipsychotic treatment
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clozapine | Other / unclassified | 250 mg | — |
| Comparator | Clozapine | Other / unclassified | 600 mg | — |
| Subject | Ziprasidone | Small molecule | 80 mg | — |
| Subject | Ziprasidone | Small molecule | 160 mg | — |